These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8057297)

  • 21. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.
    Jandu KS; Barrett V; Brockwell M; Cambridge D; Farrant DR; Foster C; Giles H; Glen RC; Hill AP; Hobbs H; Honey A; Martin GR; Salmon J; Smith D; Woollard P; Selwood DL
    J Med Chem; 2001 Mar; 44(5):681-93. PubMed ID: 11262079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
    Isaac M; Slassi M; Xin T; Arora J; O'Brien A; Edwards L; MacLean N; Wilson J; Demschyshyn L; Labrie P; Naismith A; Maddaford S; Papac D; Harrison S; Wang H; Draper S; Tehim A
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4409-13. PubMed ID: 14643336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache.
    Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L
    Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (+/-) 3-Amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole: a conformationally restricted analogue of 5-carboxamidotryptamine with selectivity for the serotonin 5-HT1D receptor.
    King FD; Brown AM; Gaster LM; Kaumann AJ; Medhurst AD; Parker SG; Parsons AA; Patch TL; Raval P
    J Med Chem; 1993 Jun; 36(13):1918-9. PubMed ID: 8515429
    [No Abstract]   [Full Text] [Related]  

  • 25. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
    Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors.
    Walsh DM; Beattie DT; Connor HE
    Eur J Pharmacol; 1995 Dec; 287(1):79-84. PubMed ID: 8666030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties.
    Laban U; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE
    Bioorg Med Chem Lett; 2001 Mar; 11(6):793-5. PubMed ID: 11277522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesity.
    Isaac M; Slassi A; O'Brien A; Edwards L; MacLean N; Bueschkens D; Lee DK; McCallum K; De Lannoy I; Demchyshyn L; Kamboj R
    Bioorg Med Chem Lett; 2000 May; 10(9):919-21. PubMed ID: 10853660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT4 receptor ligands: applications and new prospects.
    Langlois M; Fischmeister R
    J Med Chem; 2003 Jan; 46(3):319-44. PubMed ID: 12540230
    [No Abstract]   [Full Text] [Related]  

  • 34. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of oral absorption in selective 5-HT1D receptor agonists: fluorinated 3-[3-(piperidin-1-yl)propyl]indoles.
    Castro JL; Collins I; Russell MG; Watt AP; Sohal B; Rathbone D; Beer MS; Stanton JA
    J Med Chem; 1998 Jul; 41(15):2667-70. PubMed ID: 9667955
    [No Abstract]   [Full Text] [Related]  

  • 37. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
    Stepień A; Chalimoniuk M; Strosznajder J
    Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as serotonin 5-HT4 receptor agonists.
    Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):2003-8. PubMed ID: 11145160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.
    van Niel MB; Collins I; Beer MS; Broughton HB; Cheng SK; Goodacre SC; Heald A; Locker KL; MacLeod AM; Morrison D; Moyes CR; O'Connor D; Pike A; Rowley M; Russell MG; Sohal B; Stanton JA; Thomas S; Verrier H; Watt AP; Castro JL
    J Med Chem; 1999 Jun; 42(12):2087-104. PubMed ID: 10377215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.